Cancer Immunotherapy Research Institute is located in Roseville, CA. The organization was established in 2017. According to its NTEE Classification (H30) the organization is classified as: Cancer Research, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Cancer Immunotherapy Research Institute is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Gregory T Wurz Chief Sci Officer | 20 | $0 | |
Michael W Degregorio Chairman | 10 | $0 | |
Chiao Jung Kao Director | 20 | $0 |
Statement of Revenue | |
---|---|
Contributions, Gifts, Grants & Similar | $0 |
Interest on Savings | $0 |
Dividends & Interest | $0 |
Net Rental Income | $0 |
Net Gain on Sale of Assets | $0 |
Capital Gain Net Income | $0 |
Net ST Capital Gain | $0 |
Income Modifications | $0 |
Profit on Inventory Sales | $0 |
Other Income | $0 |
Total Revenue | $0 |
Statement of Expenses | |
---|---|
Compensation of officers, directors, trustees, etc | $0 |
Other employee salaries and wages | $0 |
Pension plans, employee benefits | $0 |
Interest | $0 |
Taxes | $44 |
Depreciation | $0 |
Occupancy | $0 |
Travel, conferences, and meetings | $0 |
Printing and publications | $0 |
Other expenses | $5,475 |
Total operating and administrative expenses | $5,569 |
Contributions, gifts, grants paid | $0 |
Total expenses and disbursements | $5,569 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $5,356 |
Savings and temporary cash investments | $0 |
Net Accounts receivable | $0 |
Net Pledges Receivable | $0 |
Grants receivable | $0 |
Receivables from Officers, Directors, or Controlling Persons | $0 |
Net other notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Investments - land, buildings, equipment | $0 |
Investments—mortgage loans | $0 |
Investments—other | $0 |
Net Land, buildings, and equipment | $0 |
Other assets | $0 |
Total assets | $5,356 |
Accounts payable and accrued expenses | $0 |
Grants payable | $0 |
Deferred revenue | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Mortgages and other notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $0 |
Organization Name | Assets | Revenue |
---|---|---|
Translational Research In Oncology Us Inc Los Angeles, CA | $23,537,777 | $8,265,596 |
Pediatric Cancer Research Foundation Irvine, CA | $3,627,407 | $2,821,956 |
Nevada Cancer Research Foundation Inc Las Vegas, NV | $637,661 | $2,412,271 |
The International Genomics Consortium Phoenix, AZ | $13,871,737 | $3,350,681 |
Cancer Prevention Institute of California (CPIC) Foster City, CA | $0 | $44,595 |
Vanguard Cancer Foundation Long Beach, CA | $1,374,337 | $177,388 |
Prostate Cancer Research Institute Culver City, CA | $2,240,081 | $999,786 |
Keatons Child Cancer Alliance Roseville, CA | $375,909 | $787,785 |
Ethos Discovery San Diego, CA | $1,024,175 | $920,855 |
Sino-American Cancer Foundation Arcadia, CA | $0 | $1,131,529 |
Grassrootshealth Encinitas, CA | $16,808 | $760,113 |
Hers Breast Cancer Foundation Fremont, CA | $618,137 | $748,037 |